12While it has been known for several years that viral RNAs are subject to the addition of 13 several distinct covalent modifications to individual nucleotides, collectively referred to as 14 epitranscriptomic modifications, the effect of these editing events on viral gene expression has 15 been controversial. Here, we report the purification of murine leukemia virus (MLV) genomic 16RNA to homogeneity and show that this viral RNA contains levels of N 6 -methyladenosine (m 6 A), 17 5-methylcytosine (m 5 C) and 2'O-methylated (Nm) ribonucleotides that are an order of 18 magnitude higher than detected on bulk cellular mRNAs. Mapping of m 6 A and m 5 C residues on 19 MLV transcripts identified multiple discrete editing sites and allowed the construction of MLV 20 variants bearing silent mutations that removed a subset of these sites. Analysis of the 21 replication potential of these mutants revealed a modest but significant attenuation in viral 22 replication in 3T3 cells in culture. Consistent with a positive role for m 6 A and m 5 C in viral 23 replication, we also demonstrate that overexpression of the key m 6 A reader protein YTHDF2 24 enhances MLV replication, while downregulation of the m 5 C writer NSUN2 inhibits MLV 25 replication. 26
Importance 27The data presented in this manuscript demonstrate that MLV RNAs bear an 28 exceptionally high level of the epitranscriptomic modifications m 6 A, m 5 C and Nm, thus 29 suggesting that these each facilitate some aspect of the viral replication cycle. Consistent with 30 this hypothesis, we demonstrate that mutational removal of a subset of these m 6 A or m 5 C 31 modifications from MLV transcripts inhibits MLV replication in cis and a similar result was also 32 observed upon manipulation of the level of expression of key cellular epitranscriptomic cofactors 33 in trans. Together, these results argue that the addition of several different epitranscriptomic 34 modifications to viral transcripts stimulates viral gene expression and suggest that MLV has 35 therefore evolved to maximize the level of these modifications that are added to viral RNAs. 36